| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |